{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:33:32Z","timestamp":1793306012045,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["218550\/Z\/19\/Z"],"award-info":[{"award-number":["218550\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N006364\/2"],"award-info":[{"award-number":["MR\/N006364\/2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W502649\/1"],"award-info":[{"award-number":["MR\/W502649\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V033417\/1"],"award-info":[{"award-number":["MR\/V033417\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019434","name":"NIHR Exeter Clinical Research Facility","doi-asserted-by":"publisher","award":["NIHR203320"],"award-info":[{"award-number":["NIHR203320"]}],"id":[{"id":"10.13039\/501100019434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SBF002\/1076"],"award-info":[{"award-number":["SBF002\/1076"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000737","name":"University of Exeter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.mucimm.2025.11.004","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:06:19Z","timestamp":1763658379000},"page":"1587-1598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Activation status of airway immune cells is a defining feature of severe asthma, regardless of fungal sensitisation"],"prefix":"10.1016","volume":"19","author":[{"given":"Emily L.","family":"Plumpton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.P.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Steward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Hussell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.C.","family":"Horsnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Niven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5208-4985","authenticated-orcid":false,"given":"Peter C.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.mucimm.2025.11.004_b0005","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.mucimm.2025.11.004_b0010","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/resp.14590","article-title":"Asthma in developing countries in the Asia\u2010Pacific Region (APR)","volume":"28","author":"Yasaratne","year":"2023","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-023-02475-6","article-title":"Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"24","author":"Wang","year":"2023","journal-title":"Respiratory Research"},{"issue":"5","key":"10.1016\/j.mucimm.2025.11.004_b0020","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/ppul.26932","article-title":"Outdoor air pollution and near\u2010fatal\/fatal asthma attacks in children: a systematic review","volume":"59","author":"Varghese","year":"2024","journal-title":"Pediatric Pulmonology."},{"issue":"4","key":"10.1016\/j.mucimm.2025.11.004_b0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of Severe Asthma Worldwide","volume":"157","author":"Wang","year":"2020","journal-title":"Chest."},{"issue":"2","key":"10.1016\/j.mucimm.2025.11.004_b0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"European Respiratory Journal."},{"issue":"11","key":"10.1016\/j.mucimm.2025.11.004_b0035","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/biomedicines9111684","article-title":"Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life","volume":"9","author":"Ricciardolo","year":"2021","journal-title":"Biomedicines."},{"issue":"3","key":"10.1016\/j.mucimm.2025.11.004_b0040","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaip.2020.09.051","article-title":"The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of patients with Severe Asthma","volume":"9","author":"Fr\u00f8ssing","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology. In Practice."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00528-2020","article-title":"Treatment options in type-2 low asthma","volume":"57","author":"Hinks","year":"2021","journal-title":"European Respiratory Journal."},{"issue":"4","key":"10.1016\/j.mucimm.2025.11.004_b0050","article-title":"P48\u2005the \u2018T2-low\u2019 asthma phenotype: could it just be T2-high asthma treated with corticosteroids?","volume":"73","author":"Jackson","year":"2018","journal-title":"Thorax."},{"issue":"7","key":"10.1016\/j.mucimm.2025.11.004_b0055","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221212","article-title":"Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight","volume":"220","author":"Howell","year":"2023","journal-title":"Journal of Experimental Medicine."},{"issue":"4","key":"10.1016\/j.mucimm.2025.11.004_b0060","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/biomedicines11041226","article-title":"T2-Low Asthma: a Discussed but still Orphan Disease","volume":"11","author":"Peri","year":"2023","journal-title":"Biomedicines."},{"issue":"3","key":"10.1016\/j.mucimm.2025.11.004_b0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1183\/09031936.06.00074705","article-title":"The link between fungi and severe asthma: a summary of the evidence","volume":"27","author":"Denning","year":"2006","journal-title":"European Respiratory Journal."},{"issue":"7","key":"10.1016\/j.mucimm.2025.11.004_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"The Lancet Infectious Diseases."},{"issue":"5","key":"10.1016\/j.mucimm.2025.11.004_b0075","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/cea.12426","article-title":"Aspergillus fumigatus proteases, Asp f 5 and Asp f 13, are essential for airway inflammation and remodelling in a murine inhalation model","volume":"45","author":"Namvar","year":"2015","journal-title":"Clinical & Experimental Allergy."},{"key":"10.1016\/j.mucimm.2025.11.004_b0080","article-title":"Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey","volume":"325(7361):411-","author":"Zureik","year":"2002","journal-title":"BMJ."},{"issue":"3","key":"10.1016\/j.mucimm.2025.11.004_b0085","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2024.10.040","article-title":"Aspergillus-mediated allergic airway inflammation is triggered by dendritic cell recognition of a defined spore morphotype","volume":"155","author":"Houlder","year":"2025","journal-title":"Journal of Allergy and Clinical Immunology."},{"issue":"5","key":"10.1016\/j.mucimm.2025.11.004_b0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1034\/j.1398-9995.2000.00293.x","article-title":"Sensitivity to fungal allergens is a risk factor for life\u2010threatening asthma","volume":"55","author":"Black","year":"2000","journal-title":"Allergy."},{"issue":"131","key":"10.1016\/j.mucimm.2025.11.004_b0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09059180.00007413","article-title":"Allergic aspergillosis of the respiratory tract","volume":"23","author":"Shah","year":"2014","journal-title":"European Respiratory Review."},{"issue":"8","key":"10.1016\/j.mucimm.2025.11.004_b0100","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clinical & Experimental Allergy."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-7022-4-14","article-title":"Fungal allergy in asthma\u2013state of the art and research needs","volume":"4","author":"Denning","year":"2014","journal-title":"Clinical and Translational Allergy."},{"issue":"3","key":"10.1016\/j.mucimm.2025.11.004_b0110","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2020.10.e27","article-title":"Allergic bronchopulmonary aspergillosis misdiagnosed as recurrent pneumonia","volume":"10","author":"Jiang","year":"2020","journal-title":"Asia Pacific Allergy."},{"issue":"3","key":"10.1016\/j.mucimm.2025.11.004_b0115","article-title":"Clinical Analysis of 77 patients with Allergic Bronchopulmonary Aspergillosis in Peking Union Medical College Hospital","volume":"39","author":"Zhang","year":"2017","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55663-3","article-title":"Mgl2+ cDC2s coordinate fungal allergic airway type 2, but not type 17, inflammation in mice","volume":"16","author":"Cook","year":"2025","journal-title":"Nature Communications."},{"issue":"2","key":"10.1016\/j.mucimm.2025.11.004_b0125","article-title":"Airway Macrophages Encompass Transcriptionally and Functionally Distinct Subsets Altered by smoking. American Thoracic","volume":"67","author":"Li\u00e9geois","year":"2022","journal-title":"Society."},{"issue":"6","key":"10.1016\/j.mucimm.2025.11.004_b0130","article-title":"Random Forests for Genomic Data Analysis","volume":"99","author":"Ishwaran","year":"2012","journal-title":"Genomics."},{"issue":"2","key":"10.1016\/j.mucimm.2025.11.004_b0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4049\/jimmunol.2100011","article-title":"HLA-DR Marks recently Divided Antigen-specific Effector CD4 T Cells in active Tuberculosis patients","volume":"207","author":"Tippalagama","year":"2021","journal-title":"The Journal of Immunology."},{"key":"10.1016\/j.mucimm.2025.11.004_b0140","doi-asserted-by":"crossref","unstructured":"Cibri\u00e1n D, S\u00e1nchez\u2010Madrid F. CD69: from activation marker to metabolic gatekeeper. European Journal of Immunology. 2017; doi: 47(6):946-53. 10.1002\/eji.201646837.","DOI":"10.1002\/eji.201646837"},{"issue":"12","key":"10.1016\/j.mucimm.2025.11.004_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2008.08.011","article-title":"Loss of CD127 expression links immune activation and CD4+ T cell loss in HIV infection","volume":"16","author":"Kiazyk","year":"2008","journal-title":"Trends in Microbiology."},{"issue":"8","key":"10.1016\/j.mucimm.2025.11.004_b0150","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.180.8.5582","article-title":"CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection","volume":"180","author":"Dunham","year":"2008","journal-title":"The Journal of Immunology."},{"issue":"6","key":"10.1016\/j.mucimm.2025.11.004_b0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.anai.2022.07.027","article-title":"T-cell responses in asthma exacerbations","volume":"129","author":"Bryant","year":"2022","journal-title":"Annals of Allergy, Asthma & Immunology."},{"issue":"6","key":"10.1016\/j.mucimm.2025.11.004_b0160","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2021.02.016","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0165","doi-asserted-by":"crossref","DOI":"10.1007\/s00005-021-00608-7","article-title":"\u03b3\u03b4 T Lymphocytes in Asthma: a Complicated Picture","volume":"69","author":"Zarobkiewicz","year":"2021","journal-title":"Archivum Immunologiae et Therapiae Experimentalis."},{"issue":"7","key":"10.1016\/j.mucimm.2025.11.004_b0170","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","article-title":"CD28\u2212 T cells: their role in the age-associated decline of immune function","volume":"30","author":"Weng","year":"2009","journal-title":"Trends in Immunology."},{"issue":"11","key":"10.1016\/j.mucimm.2025.11.004_b0175","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1111\/ajt.12937","article-title":"CD28 negative T Cells: is their loss our gain?","volume":"14","author":"Mou","year":"2014","journal-title":"American Journal of Transplantation."},{"issue":"7","key":"10.1016\/j.mucimm.2025.11.004_b0180","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/cea.12297","article-title":"Myeloid dendritic cells type 2 after allergen inhalation in asthmatic subjects","volume":"44","author":"Dua","year":"2014","journal-title":"Clinical & Experimental Allergy."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.04.006","article-title":"Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma","volume":"126","author":"Dua","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology."},{"issue":"6644","key":"10.1016\/j.mucimm.2025.11.004_b0190","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/42030","article-title":"Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells","volume":"388","author":"Cella","year":"1997","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.mucimm.2025.11.004_b0195","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nri1845","article-title":"Dendritic cells in a mature age","volume":"6","author":"Reis","year":"2006","journal-title":"Nature Reviews Immunology."},{"issue":"12","key":"10.1016\/j.mucimm.2025.11.004_b0200","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nature Reviews Immunology."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0205","doi-asserted-by":"crossref","DOI":"10.1093\/discim\/kyad009","article-title":"Comparative phenotype of circulating versus tissue immune cells in human lung and blood compartments during health and disease","volume":"2","author":"Colombo","year":"2023","journal-title":"Discovery Immunology."},{"key":"10.1016\/j.mucimm.2025.11.004_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00941","article-title":"Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?","volume":"8","author":"Vroman","year":"2017","journal-title":"Frontiers in Immunology."},{"issue":"2","key":"10.1016\/j.mucimm.2025.11.004_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.alit.2019.11.002","article-title":"Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings","volume":"69","author":"Yun","year":"2020","journal-title":"Allergology International."},{"key":"10.1016\/j.mucimm.2025.11.004_b0220","unstructured":"Hartnell A, Robinson D, Kay A, et al. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology. 1993; 80(2). doi: PMC1422202."},{"issue":"4","key":"10.1016\/j.mucimm.2025.11.004_b0225","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1073\/pnas.86.4.1348","article-title":"Mature human eosinophils have the capacity to express HLA-DR","volume":"86","author":"Lucey","year":"1989","journal-title":"Proceedings of the National Academy of Sciences."},{"key":"10.1016\/j.mucimm.2025.11.004_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105875","article-title":"Elevated eosinophils, IL5 and IL8 in induced sputum in asthma patients with accelerated FEV1 decline","volume":"162","author":"Marc-Malovrh","year":"2020","journal-title":"Respiratory Medicine."},{"key":"10.1016\/j.mucimm.2025.11.004_b0235","unstructured":"GINA. Pocket Guide For Asthma Management and Prevention. https:\/\/ginasthma.org\/wp-content\/uploads\/2023\/07\/GINA-2023-Pocket-Guide-WMS.pdf Date last updated: July 2023. Date last accessed: May 12 2025."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0240","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-02028-3","article-title":"Clinical and cytokine patterns of uncontrolled asthma with and without comorbid chronic rhinosinusitis: a cross-sectional study","volume":"23","author":"Huang","year":"2022","journal-title":"Respiratory Research."},{"issue":"13","key":"10.1016\/j.mucimm.2025.11.004_b0245","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.3390\/jcm13133721","article-title":"Upper Airway Alarmin Cytokine Expression in Asthma of Different Severities","volume":"13","author":"Marriott","year":"2024","journal-title":"Journal of Clinical Medicine."},{"issue":"11","key":"10.1016\/j.mucimm.2025.11.004_b0250","article-title":"Increased TGF\u03b21, VEGF and IFN-\u03b3 in the Sputum of Severe Asthma patients with Bronchiectasis","volume":"60","author":"Ma","year":"2024","journal-title":"Archivos De Bronconeumologia."},{"issue":"6","key":"10.1016\/j.mucimm.2025.11.004_b0255","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/cea.12269","article-title":"Interferon gene expression in sputum cells correlates with the Asthma Index score during virus\u2010induced exacerbations","volume":"44","author":"Schwantes","year":"2014","journal-title":"Clinical & Experimental Allergy."},{"key":"10.1016\/j.mucimm.2025.11.004_b0260","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ebiom.2017.03.033","article-title":"A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines following Experimental Rhinovirus Infection in Allergic Asthma: increased Interferons (IFN-\u03b3 and IFN-\u03bb) and Type 2 Inflammation (IL-5 and IL-13)","volume":"19","author":"Hansel","year":"2017","journal-title":"EBioMedicine."},{"issue":"12","key":"10.1016\/j.mucimm.2025.11.004_b0265","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","article-title":"Neutrophilic Inflammation in Asthma and Association with Disease Severity","volume":"38","author":"Ray","year":"2017","journal-title":"Trends in Immunology."},{"issue":"7","key":"10.1016\/j.mucimm.2025.11.004_b0270","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.4049\/jimmunol.1701455","article-title":"Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: a potential Biomarker of Severe Refractory Disease","volume":"200","author":"Li","year":"2018","journal-title":"The Journal of Immunology."},{"issue":"167","key":"10.1016\/j.mucimm.2025.11.004_b0275","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0144-2022","article-title":"Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD","volume":"32","author":"Calderon","year":"2023","journal-title":"European Respiratory Review."},{"issue":"6","key":"10.1016\/j.mucimm.2025.11.004_b0280","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/anae.14563","article-title":"Airway management research: what problem are we trying to solve?","volume":"74","author":"Mcgrenaghan","year":"2019","journal-title":"Anaesthesia."},{"issue":"5","key":"10.1016\/j.mucimm.2025.11.004_b0285","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161593","article-title":"Antigen specificity and cross-reactivity drive functionally diverse anti\u2013Aspergillus fumigatus T cell responses in cystic fibrosis","volume":"133","author":"Schwarz","year":"2023","journal-title":"Journal of Clinical Investigation."},{"key":"10.1016\/j.mucimm.2025.11.004_b0290","doi-asserted-by":"crossref","unstructured":"Moon H-G, Eccles JD, Kim S-J, et al. Complement C1q essential for aeroallergen sensitization via CSF1R+ conventional dendritic cells type 2. Journal of Allergy and Clinical Immunology. 2023; 152(5):1141-52.e2. doi: 10.1016\/j.jaci.2023.07.016.","DOI":"10.1016\/j.jaci.2023.07.016"},{"issue":"2","key":"10.1016\/j.mucimm.2025.11.004_b0295","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.rmed.2009.09.011","article-title":"Effect of omalizumab on peripheral blood eosinophilia in allergic asthma","volume":"104","author":"Massanari","year":"2010","journal-title":"Respiratory Medicine."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0300","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1056-4","article-title":"Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis","volume":"20","author":"Prazma","year":"2019","journal-title":"Respiratory Research."},{"key":"10.1016\/j.mucimm.2025.11.004_b0305","article-title":"Inhaled corticosteroid use and its implication in peripheral eosinophil level","volume":"145(2):AB28","author":"Franco","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology."},{"issue":"5","key":"10.1016\/j.mucimm.2025.11.004_b0310","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02523-2017","article-title":"Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study","volume":"51","author":"Humbert","year":"2018","journal-title":"European Respiratory Journal."},{"issue":"68","key":"10.1016\/j.mucimm.2025.11.004_b0315","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi9768","article-title":"An IL-9\u2013pulmonary macrophage axis defines the allergic lung inflammatory environment","volume":"7","author":"Fu","year":"2022","journal-title":"Science Immunology."},{"issue":"4","key":"10.1016\/j.mucimm.2025.11.004_b0320","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1034\/j.1398-9995.2000.00474.x","article-title":"Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum","volume":"55","author":"Yamada","year":"2000","journal-title":"Allergy."},{"issue":"7","key":"10.1016\/j.mucimm.2025.11.004_b0325","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.rmed.2007.01.026","article-title":"Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin","volume":"101","author":"Xu","year":"2007","journal-title":"Respiratory Medicine."},{"issue":"6","key":"10.1016\/j.mucimm.2025.11.004_b0330","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1067\/mai.2003.1485","article-title":"Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes","volume":"111","author":"Erpenbeck","year":"2003","journal-title":"Journal of Allergy and Clinical Immunology."},{"issue":"1","key":"10.1016\/j.mucimm.2025.11.004_b0335","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0091-6749(00)90185-4","article-title":"IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma","volume":"105","author":"Shimbara","year":"2000","journal-title":"Journal of Allergy and Clinical Immunology."},{"issue":"6","key":"10.1016\/j.mucimm.2025.11.004_b0340","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1183\/09031936.96.09061174","article-title":"Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination","volume":"9","author":"Pizzichini","year":"1996","journal-title":"European Respiratory Journal."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021925001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021925001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:23:45Z","timestamp":1793305425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021925001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1933021925001217"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2025.11.004","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation status of airway immune cells is a defining feature of severe asthma, regardless of fungal sensitisation","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2025.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}